Mitsubishi Tanabe And Hitachi Establish Therapeutic Robot Center In Japan
This article was originally published in PharmAsia News
Japanese medical device makers Hitachi and Shimadzu, mechatronics giant Yaskawa Denki and drug company Mitsubishi Tanabe Pharma July 9 jointly established a medical robot center in Fukuoka. Based inside Kyushu University Hospital, the center will employ advanced technology to develop endoscopic robots able to operate inside the human body. The Japanese government will provide ¥1.2 billion to encourage innovation in therapeutic robot technology. The center also plans to develop devices to conduct remote surgeries and chemical compounds to detect tumors with diameters of 1 millimeter. (Click here for more - Japanese language
You may also be interested in...
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
Pharmaceutical manufacturers should have already begun serializing products and verifying saleable returns to comply with DSCSA, says FDA official who also asserted that licensing standards for wholesale distributors and third-party logistics providers will be forthcoming. This rule is already six years overdue under a DSCSA mandated timeline.
On a “strong first half of the base,” P&G increased FY2021 guidance for organic sales growth and core earnings per share despite a “sequential deceleration” in US consumption in its categories in December and so far in January.